Last rescrape: 2 days ago
Next scheduled rescrape: in 3 days
Showing 1 edited version
Scraped on 13/12/2025, 04:48:25 UTC
I want to tell you guys something that I have not told anyone.

Half a year ago, I decided to circle back academically and two months ago, I started doing a degree in the biomedical field. (As if physics hadn't been traumatic enough.)
You're never too old/lazy to start something new.  Grin

Good luck for the degree you started.

I completed by Post Graduate studies a year ago and I am too lazy in starting my Phd program. Wish me luck and courage.

Thanks!

I totally get what you mean.

My laziness was unmatched for a long time.

But right now?
Personalized medicine? AI-customized drugs? Woah. This stuff is interesting, I barely find time to shitpost here. It is that serious.



Congrats, a valiant endeavor. If I had all the money & time in the world I would concentrate full-time on finishing my Master's degree in a similar field. And I'd just do it for fun, or self-betterment.

Thank you!
I am definitely hoping to better myself and make a difference. But it is fun.  Grin


I want to tell you guys something that I have not told anyone.

Half a year ago, I decided to circle back academically and two months ago, I started doing a degree in the biomedical field. (As if physics hadn't been traumatic enough.)
You're never too old/lazy to start something new.  Grin

Congrats! That's the spirit! Never stop learning!

Thanks! It's literally impossible to stop learning.
I think instead of "I think, thefore I am" it should be "I learn, therefore I am". It just makes more sense.


The most difficult part of the biomedical research and development (in a company) is the fact that trials take an incredibly long time and have to be done in succession: phaseI, phase II, phase III.

Very often a decade or more passes before the molecule is fully vetted and by that time a presumably better molecule might enter phase I/II and there is no upside for the first medicine.

I am talking about this from a biotech investor perspective. It's not an AI development speed, not even close.
Original archived Re: Wall Observer BTC/USD - Bitcoin price movement tracking & discussion
Scraped on 13/12/2025, 04:42:47 UTC
I want to tell you guys something that I have not told anyone.

Half a year ago, I decided to circle back academically and two months ago, I started doing a degree in the biomedical field. (As if physics hadn't been traumatic enough.)
You're never too old/lazy to start something new.  Grin

Good luck for the degree you started.

I completed by Post Graduate studies a year ago and I am too lazy in starting my Phd program. Wish me luck and courage.

Thanks!

I totally get what you mean.

My laziness was unmatched for a long time.

But right now?
Personalized medicine? AI-customized drugs? Woah. This stuff is interesting, I barely find time to shitpost here. It is that serious.



Congrats, a valiant endeavor. If I had all the money & time in the world I would concentrate full-time on finishing my Master's degree in a similar field. And I'd just do it for fun, or self-betterment.

Thank you!
I am definitely hoping to better myself and make a difference. But it is fun.  Grin


I want to tell you guys something that I have not told anyone.

Half a year ago, I decided to circle back academically and two months ago, I started doing a degree in the biomedical field. (As if physics hadn't been traumatic enough.)
You're never too old/lazy to start something new.  Grin

Congrats! That's the spirit! Never stop learning!

Thanks! It's literally impossible to stop learning.
I think instead of "I think, thefore I am" it should be "I learn, therefore I am". It just makes more sense.


The most difficult part of the biomedical research and development (in acompany) is the fact that trials take an incredibly long time and have to be done in succession: phaseI, phase II, phase III.

Very often a decade or more passes before the molecule is fully vetted and by that time a presumably better molecule might enter phase I/II and there is no upside for the first medicine. A am talking about this from a biotech investor perspective. It's not an AI development speed, not even close.